Svante Norgren

This study investigates N-acetylcysteine amide (NACA) as a prophylactic treatment for acute GvHD in a mouse model, showing reduced disease severity and improved survival without affecting donor engraftment.

This study shows that N-acetylcysteine amide (NACA) reduces cyclophosphamide-induced endothelial damage in mice by decreasing apoptosis, oxidative stress, and restoring nitric oxide synthase function.